P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma by Conrad-Amadeus Voltin, Stefanie Kreissl, Helen Kaul, Ina Bühnen, Jasmin Mettler, Thomas Pabst, Dennis A. Eichenauer, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann, Carsten Kobe

Get full text

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma by Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann

Get full text

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group by Peter Borchmann, Alden Moccia, Richard Greil, Mark Herzberg, Alexander Fosså, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Johannes Hellmuth, Stephan Mathas, Josée. M. Zijlstra, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratush Giri, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Theodor Eich, Christian Baues, Michael Hallek, Carsten Kobe, Volker Diehl, Andreas Engert

Get full text